Pal Czobor Selected Research

Haloperidol (Haldol)

7/2014	Depression and impulsivity as pathways to violence: implications for antiaggressive treatment.
1/2012	Executive function predicts response to antiaggression treatment in schizophrenia: a randomized controlled trial.
8/2011	Cholesterol and cognition in schizophrenia: a double-blind study of patients randomized to clozapine, olanzapine and haloperidol.
7/2011	Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
5/2009	Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.
6/2006	Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
4/2006	Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.
11/2005	Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies.
8/2005	Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).
7/2005	Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pal Czobor Research Topics

Disease

26	Schizophrenia (Dementia Praecox) 01/2021 - 02/2002
14	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 02/2002
4	Weight Gain 07/2011 - 02/2002
2	Major Depressive Disorder (Major Depressive Disorders) 01/2012 - 01/2006
2	Treatment-Resistant Schizophrenia 04/2004 - 10/2002
1	Infections 01/2022
1	Alcoholism (Alcohol Abuse) 12/2018
1	Anhedonia 01/2012
1	Fatigue 01/2012
1	Sleepiness 11/2011
1	Dizziness (Lightheadedness) 11/2011
1	Headache (Headaches) 11/2011
1	Nausea 11/2011
1	Depressive Disorder (Melancholia) 12/2005
1	Antisocial Personality Disorder (Antisocial Personality) 06/2004
1	Learning Disabilities (Learning Disability) 06/2004
1	Hyperglycemia 02/2003
1	Hypercholesterolemia 02/2003

Drug/Important Bio-Agent (IBA)

16	Haloperidol (Haldol)FDA LinkGeneric 07/2014 - 02/2002
15	Antipsychotic Agents (Antipsychotics)IBA 07/2011 - 02/2002
14	Olanzapine (Zyprexa)FDA Link 07/2014 - 02/2002
13	Clozapine (Clozaril)FDA LinkGeneric 07/2014 - 02/2002
9	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2007 - 02/2002
2	Antidepressive Agents (Antidepressants)IBA 01/2012 - 01/2006
2	CholesterolIBA 08/2011 - 02/2003
2	ziprasidone (Geodon)FDA Link 07/2011 - 04/2006
2	Quetiapine Fumarate (Seroquel)FDA Link 07/2011 - 08/2005
2	Glucose (Dextrose)FDA LinkGeneric 05/2009 - 02/2003
1	N 30IBA 01/2022
1	N-ethylguanidinoacetate (NEGA)IBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2018
1	1- (3,4- dichlorophenyl)- 3- azabicyclo- (3.1.0)hexane hydrochlorideIBA 01/2012
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2011
1	Amisulpride (Solian)IBA 07/2011
1	Blood Glucose (Blood Sugar)IBA 05/2009
1	LipidsIBA 05/2009
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2006
1	Serotonin (5 Hydroxytryptamine)IBA 01/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2006
1	Dopamine (Intropin)FDA LinkGeneric 01/2006
1	Opioid Analgesics (Opioids)IBA 12/2005
1	Aripiprazole (Abilify)FDA Link 11/2005
1	G-protein beta3 subunitIBA 10/2005
1	3' Untranslated Regions (3' UTR)IBA 05/2005
1	ProlactinIBA 01/2004

Therapy/Procedure

1	Therapeutics 07/2011
1	Length of Stay 06/2006
1	Patient Readmission 06/2004
1	Drug Therapy (Chemotherapy) 05/2003
1	Aftercare (After-Treatment) 10/2002